Type I Marine Collagen (Pisces)

Type I marine collagen from fish contains hydroxyproline and glycine amino acids that theoretically support collagen synthesis pathways. Current research focuses only on extraction methods with no documented clinical health benefits.

Origin & History

Type I Marine Collagen (Pisces) is a fibrillar protein extracted from the skin, scales, or swim bladders of marine fish including sardines, yellowfin tuna, Atlantic cod, and Asian sea bass. Production involves acid-solubilized extraction using 0.5 M acetic acid (3 days at 4°C) or enzymatic hydrolysis with proteases, yielding 50-63% collagen on dry weight basis.

Historical & Cultural Context

No traditional or historical medicinal use documented in the research. Current applications emphasize modern industrial extraction from fish processing by-products rather than any ethnomedical heritage.

Health Benefits

• No clinical health benefits documented - available research focuses only on extraction methods and structural characterization
• Potential biomedical applications suggested but not clinically tested
• Native triple-helical structure preserved during extraction may support theoretical tissue engineering uses (no clinical evidence)
• High purity confirmed by spectroscopic analyses but therapeutic effects unverified
• Industrial potential noted for pharmaceutical applications without human trial data

How It Works

Type I marine collagen provides hydroxyproline, glycine, and proline amino acids that serve as building blocks for endogenous collagen synthesis. The preserved triple-helical structure may theoretically interact with collagen receptors and support tissue matrix formation. However, specific molecular pathways and receptor interactions remain unstudied in clinical settings.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the research dossier for Type I Marine Collagen. Available studies focus exclusively on extraction methodologies, structural characterization via FTIR and X-ray diffraction, and yield optimization without any clinical outcome data.

Clinical Summary

No clinical trials have evaluated the health benefits of Type I marine collagen supplements. Available research consists entirely of extraction methodology studies and structural characterization analyses. While some papers suggest potential biomedical applications, these remain theoretical without human testing. The evidence base is limited to laboratory extraction techniques and molecular structure documentation.

Nutritional Profile

Type I Marine Collagen (Pisces) is composed predominantly of protein, typically 85–95% by dry weight, with the characteristic amino acid composition of fibrillar collagen: glycine (~33% of total amino acids), proline (~13%), hydroxyproline (~9–12%), alanine (~11%), and glutamic acid (~~7%). Hydroxyproline content is notably lower than bovine Type I collagen, reflecting the cold-water adaptation of fish species. Total nitrogen content approximates 16–18% by dry weight. Carbohydrate content is negligible (<1%). Lipid content is very low (<2%), though trace omega-3 fatty acid residues may persist depending on extraction purity. Ash/mineral content typically ranges 0.3–1.5% and may include trace calcium, phosphorus, sodium, and magnesium retained from fish bone or skin matrices. No significant vitamins are present. The protein is devoid of tryptophan (making it an incomplete protein by essential amino acid standards) and low in methionine and histidine. Molecular weight of extracted triple-helical chains: α1 and α2 chains at approximately 100–140 kDa each, confirmed by SDS-PAGE. Bioavailability: intact high-molecular-weight collagen has low direct bioavailability; hydrolyzed forms (collagen peptides, MW 0.3–8 kDa) demonstrate significantly improved gastrointestinal absorption. Native triple-helical structure is preserved at low processing temperatures, confirmed by FTIR and circular dichroism spectroscopy, with denaturation temperature (Td) typically 25–30°C — lower than mammalian collagen due to lower hydroxyproline density.

Preparation & Dosage

No clinically studied dosage ranges available as human trials are absent from the research. Extraction yields of 50-63% dry weight are reported for production purposes only, with no data on supplementation dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient evidence to recommend synergistic compounds

Safety & Interactions

Safety data for Type I marine collagen supplements is unavailable due to lack of clinical studies. Potential allergic reactions may occur in individuals with fish allergies. Drug interactions and contraindications have not been studied or documented. Pregnancy and breastfeeding safety cannot be determined without clinical research data.